SEC Company Response from Grant Life Sciences, Inc. (CIK 0001210336) — Jul 15, 2005
Grant Life Sciences, Inc. (CIK 0001210336)
Date: July 15, 2005 · CIK: 0001210336 · Accession: 0001144204-05-021724
AI Filing Summary & Sentiment
File numbers found in text: 333-119425
Letter
Re: Grant Life Sciences, Inc. Registration Statement on Form SB-2 File No. 333-119425
GRANT LIFE SCIENCES, INC. 64 East Winchester, Suite 205 Murray, Utah 84107
July 15, 2005
VIA FACSIMILE AND EDGAR
United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
Attention: Mary K. Fraser
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), Grant Life Sciences, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Monday July 18, 2005, or as soon thereafter as possible.
We hereby acknowledge the following:
o that should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
o the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
o the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
GRANT LIFE SCIENCES, INC.
By: /s/ Stan Yakatan ------------------------------ Name: Stan Yakatan Title: President and Chief Executive Officer
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
GRANT LIFE SCIENCES, INC.
64 East Winchester, Suite 205
Murray, Utah 84107
July 15, 2005
VIA FACSIMILE AND EDGAR
United States Securities
and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mary K. Fraser
Re: Grant Life Sciences, Inc.
Registration Statement on Form SB-2
File No. 333-119425
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the
Securities Act of 1933, as amended (the "Act"), Grant Life Sciences, Inc. (the
"Company") respectfully requests that the effective date of the registration
statement referred to above be accelerated so that it will become effective at
4:30 p.m., Eastern Time, on Monday July 18, 2005, or as soon thereafter as
possible.
We hereby acknowledge the following:
o that should the Commission or the staff, acting pursuant to
delegated authority, declare the filing effective, it does not
foreclose the Commission from taking any action with respect to the
filing;
o the action of the Commission or the staff, acting pursuant to
delegated authority, in declaring the filing effective, does not
relieve the Company from its full responsibility for the adequacy
and accuracy of the disclosure in the filing; and
o the Company may not assert staff comments and the declaration of
effectiveness as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the
United States.
GRANT LIFE SCIENCES, INC.
By: /s/ Stan Yakatan
------------------------------
Name: Stan Yakatan
Title: President and Chief Executive Officer
</TEXT>
</DOCUMENT>